The University of Chicago Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Thistlethwaite, J.
One or more keywords matched the following items that are connected to Thistlethwaite, J.
Item TypeName
Concept Muromonab-CD3
Academic Article A randomized clinical trial of induction therapy with OKT3 in kidney transplantation.
Academic Article Immunosuppressive effects of anti-CD3 MAb and soluble co-stimulatory molecules.
Academic Article General aspects of cytokine-release syndrome: timing and incidence of symptoms.
Academic Article OKT3 induction in pediatric renal transplantation.
Academic Article Outcome of monoclonal antibody induction and anti-rejection therapy in pancreas transplantation.
Academic Article Treatment of steroid-resistant rejection with tacrolimus prior to OKT3 in liver transplant recipients.
Academic Article Tacrolimus therapy for refractory renal allograft rejection: experience with steroid withdrawal.
Academic Article OKT3 escalating dose regimens provide effective therapy for renal allograft rejection.
Academic Article Posttransplant lymphoproliferative disease in pediatric liver transplantation. Interplay between primary Epstein-Barr virus infection and immunosuppression.
Academic Article Humanized OKT3 antibodies: successful transfer of immune modulating properties and idiotype expression.
Academic Article Role of protocol biopsies in the treatment of refractory renal allograft rejection with FK 506.
Academic Article Liver transplantation in the first three months of life.
Academic Article Association between liver transplantation for Langerhans cell histiocytosis, rejection, and development of posttransplant lymphoproliferative disease in children.
Academic Article Tacrolimus treatment of steroid-resistant rejection provides economic advantages compared with OKT3 therapy.
Academic Article Humanized, nonmitogenic OKT3 antibody, huOKT3 gamma(Ala-Ala): initial clinical experience.
Academic Article Effect of a single amino acid mutation on the activating and immunosuppressive properties of a "humanized" OKT3 monoclonal antibody.
Academic Article Tacrolimus therapy for refractory acute renal allograft rejection: a 4-year experience with an aggressive approach.
Academic Article Phase I trial of a humanized, Fc receptor nonbinding OKT3 antibody, huOKT3gamma1(Ala-Ala) in the treatment of acute renal allograft rejection.
Academic Article OKT3 F(ab')2 fragments--retention of the immunosuppressive properties of whole antibody with marked reduction in T cell activation and lymphokine release.
Academic Article OKT3 therapy for hepatic allograft rejection. Differential response in adults and children.
Academic Article Activation of human T cells in vivo following treatment of transplant recipients with OKT3.
Academic Article Selective OKT3 induction therapy in adult cadaveric-donor renal transplant recipients.
Academic Article T lymphocyte activation following OKT3 treatment.
Academic Article The use of OKT3 to treat steroid-resistant renal allograft rejection in patients receiving cyclosporine.
Academic Article OKT3 therapy for hepatic allograft rejection: comparison of results in adults and children.
Academic Article OKT3 treatment of steroid-resistant renal allograft rejection.
Academic Article Use of a brief steroid trial before initiating OKT3 therapy for renal allograft rejection.
Academic Article OKT3 prophylaxis improves long-term renal graft survival in high-risk patients as compared to cyclosporine: combined results from the prospective, randomized Belgian and US studies.
Academic Article Complications and monitoring of OKT3 therapy.
Academic Article Inhibition of T-cell activation by an anti-human class I MHC reactive monoclonal antibody occurs at a point distal to TCR-CD3 mediated signal transduction.
Academic Article A non-activating "humanized" anti-CD3 monoclonal antibody retains immunosuppressive properties in vivo.
Academic Article Tacrolimus for primary treatment of steroid-resistant hepatic allograft rejection.
Academic Article OKT3 prophylaxis in renal grafts with prolonged cold ischemia times: association with improvement in long-term survival.
Academic Article Reexposure to OKT3 in renal allograft recipients.
Academic Article Evolving use of OKT3 monoclonal antibody for treatment of renal allograft rejection.
Search Criteria
  • Muromonab CD3